Construction and Characterization of an Escherichia coli Mutant Producing Kdo2-Lipid A

Marine Drugs

Jianli Wang¹  Wenjian Ma¹  Zhou Wang¹  Ye Li¹ 

[1] State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; E-Mails:

关键词: Kdo₂-lipid A;    lipopolysaccharide;    rfaD;    Escherichia coli;    ESI/MS;    membrane permeability;    autoaggregation;    biofilm;   

DOI  :  10.3390/md12031495

来源: mdpi

【 摘 要 】

3-deoxy-d-manno-oct-2-ulosonic acid (Kdo)₂-lipid A is the conserved structure domain of lipopolysaccharide found in most Gram-negative bacteria, and it is believed to stimulate the innate immune system through the TLR4/MD2 complex. Therefore, Kdo₂-lipid A is an important stimulator for studying the mechanism of the innate immune system and for developing bacterial vaccine adjuvants. Kdo₂-lipid A has not been chemically synthesized to date and could only be isolated from an Escherichia coli mutant strain, WBB06. WBB06 cells grow slowly and have to grow in the presence of tetracycline. In this study, a novel E. coli mutant strain, WJW00, that could synthesize Kdo₂-lipid A was constructed by deleting the rfaD gene from the genome of E. coli W3110. The rfaD gene encodes ADP-l-glycero-d-manno-heptose-6-epimerase RfaD. Based on the analysis by SDS-PAGE, thin layer chromatography (TLC) and electrospray ionization mass spectrometry (ESI/MS), WJW00 could produce similar levels of Kdo₂-lipid A to WBB06. WJW00 cells grow much better than WBB06 cells and do not need to add any antibiotics during growth. Compared with the wild-type strain, W3110, WJW00 showed increased hydrophobicity, higher cell permeability, greater autoaggregation and decreased biofilm-forming ability. Therefore, WJW00 could be a more suitable strain than WBB06 for producing Kdo₂-lipid A and a good base strain for developing lipid A adjuvants.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland.